JP2022514817A - 選択的に濡れやすい、酸素透過性のレンズ - Google Patents
選択的に濡れやすい、酸素透過性のレンズ Download PDFInfo
- Publication number
- JP2022514817A JP2022514817A JP2021530958A JP2021530958A JP2022514817A JP 2022514817 A JP2022514817 A JP 2022514817A JP 2021530958 A JP2021530958 A JP 2021530958A JP 2021530958 A JP2021530958 A JP 2021530958A JP 2022514817 A JP2022514817 A JP 2022514817A
- Authority
- JP
- Japan
- Prior art keywords
- silicone
- sigma
- lens
- monomer
- mold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052760 oxygen Inorganic materials 0.000 title claims description 24
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims description 23
- 239000001301 oxygen Substances 0.000 title claims description 23
- 239000000178 monomer Substances 0.000 claims abstract description 196
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 169
- 238000005266 casting Methods 0.000 claims abstract description 7
- 239000000017 hydrogel Substances 0.000 claims description 130
- 229920000642 polymer Polymers 0.000 claims description 116
- 239000000463 material Substances 0.000 claims description 78
- 239000000203 mixture Substances 0.000 claims description 76
- 239000007788 liquid Substances 0.000 claims description 52
- 210000001508 eye Anatomy 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 28
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims description 20
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 19
- -1 methacryloyl Chemical group 0.000 claims description 18
- 230000035699 permeability Effects 0.000 claims description 13
- 229950004354 phosphorylcholine Drugs 0.000 claims description 11
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 claims description 11
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 10
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 10
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 claims description 4
- 229940117986 sulfobetaine Drugs 0.000 claims description 4
- NMMXJQKTXREVGN-UHFFFAOYSA-N 2-(4-benzoyl-3-hydroxyphenoxy)ethyl prop-2-enoate Chemical compound OC1=CC(OCCOC(=O)C=C)=CC=C1C(=O)C1=CC=CC=C1 NMMXJQKTXREVGN-UHFFFAOYSA-N 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000005504 styryl group Chemical group 0.000 claims description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- FRSXCBKFXOXHRX-UHFFFAOYSA-N C[SiH2]O[SiH2]CCCOCCOPOCCN Chemical compound C[SiH2]O[SiH2]CCCOCCOPOCCN FRSXCBKFXOXHRX-UHFFFAOYSA-N 0.000 claims 1
- 239000011344 liquid material Substances 0.000 claims 1
- 229920002959 polymer blend Polymers 0.000 abstract description 8
- 210000000695 crystalline len Anatomy 0.000 description 276
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 34
- 238000012360 testing method Methods 0.000 description 31
- 238000004528 spin coating Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 13
- 102100026735 Coagulation factor VIII Human genes 0.000 description 13
- 206010016807 Fluid retention Diseases 0.000 description 13
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 12
- 229920001983 poloxamer Polymers 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 210000001525 retina Anatomy 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 9
- 238000000465 moulding Methods 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 208000001491 myopia Diseases 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- SONHXMAHPHADTF-UHFFFAOYSA-M sodium;2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O SONHXMAHPHADTF-UHFFFAOYSA-M 0.000 description 8
- 241001325209 Nama Species 0.000 description 7
- 239000002981 blocking agent Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000004087 cornea Anatomy 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 210000000744 eyelid Anatomy 0.000 description 7
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 7
- 230000004379 myopia Effects 0.000 description 7
- 229960000502 poloxamer Drugs 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 6
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 6
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 230000004323 axial length Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 125000005395 methacrylic acid group Chemical group 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000693 micelle Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 4
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 238000009864 tensile test Methods 0.000 description 4
- 229920002397 thermoplastic olefin Polymers 0.000 description 4
- 206010020675 Hypermetropia Diseases 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 239000003000 extruded plastic Substances 0.000 description 3
- 230000004305 hyperopia Effects 0.000 description 3
- 201000006318 hyperopia Diseases 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036040 emmetropia Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- YHOSNAAUPKDRMI-UHFFFAOYSA-N n,n-di(propan-2-yl)prop-2-enamide Chemical compound CC(C)N(C(C)C)C(=O)C=C YHOSNAAUPKDRMI-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 1
- BLFZMXOCPASACY-UHFFFAOYSA-N 1,4-bis(propan-2-ylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NC(C)C)=CC=C2NC(C)C BLFZMXOCPASACY-UHFFFAOYSA-N 0.000 description 1
- WGYZMNBUZFHYRX-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-ol Chemical compound COCC(C)OCC(C)O WGYZMNBUZFHYRX-UHFFFAOYSA-N 0.000 description 1
- LHENQXAPVKABON-UHFFFAOYSA-N 1-methoxypropan-1-ol Chemical compound CCC(O)OC LHENQXAPVKABON-UHFFFAOYSA-N 0.000 description 1
- AFXKUUDFKHVAGI-UHFFFAOYSA-N 1-methyl-3-methylidenepyrrolidin-2-one Chemical compound CN1CCC(=C)C1=O AFXKUUDFKHVAGI-UHFFFAOYSA-N 0.000 description 1
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 1
- SUSSMAWGVJTGOM-UHFFFAOYSA-N 2-[[4-[2-(2-methylprop-2-enoyloxy)ethylamino]-9,10-dioxoanthracen-1-yl]amino]ethyl 2-methylprop-2-enoate Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCCOC(=O)C(C)=C)=CC=C2NCCOC(=O)C(=C)C SUSSMAWGVJTGOM-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- MEYARNKYUHUVBB-UHFFFAOYSA-N 2-hydroxy-1-[2-(hydroxymethyl)phenyl]-2-phenylethanone Chemical compound OCC1=CC=CC=C1C(=O)C(O)C1=CC=CC=C1 MEYARNKYUHUVBB-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical class OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical class OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002507 Poloxamer 124 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- YZWHFYMJTHAFRT-UHFFFAOYSA-N [4-(2-methoxy-2-phenylacetyl)phenyl] prop-2-enoate Chemical compound COC(C(C1=CC=C(C=C1)OC(C=C)=O)=O)C1=CC=CC=C1 YZWHFYMJTHAFRT-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OAKHANKSRIPFCE-UHFFFAOYSA-L calcium;2-methylprop-2-enoate Chemical compound [Ca+2].CC(=C)C([O-])=O.CC(=C)C([O-])=O OAKHANKSRIPFCE-UHFFFAOYSA-L 0.000 description 1
- TXTCTCUXLQYGLA-UHFFFAOYSA-L calcium;prop-2-enoate Chemical compound [Ca+2].[O-]C(=O)C=C.[O-]C(=O)C=C TXTCTCUXLQYGLA-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DOMLXBPXLNDFAB-UHFFFAOYSA-N ethoxyethane;methyl prop-2-enoate Chemical compound CCOCC.COC(=O)C=C DOMLXBPXLNDFAB-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000012705 liquid precursor Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- RLQOUIUVEQXDPW-UHFFFAOYSA-M lithium;2-methylprop-2-enoate Chemical compound [Li+].CC(=C)C([O-])=O RLQOUIUVEQXDPW-UHFFFAOYSA-M 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000088 plastic resin Substances 0.000 description 1
- 229940093448 poloxamer 124 Drugs 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- LLLCSBYSPJHDJX-UHFFFAOYSA-M potassium;2-methylprop-2-enoate Chemical compound [K+].CC(=C)C([O-])=O LLLCSBYSPJHDJX-UHFFFAOYSA-M 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/04—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
- C08F230/08—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing silicon
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F30/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F30/04—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
- C08F30/08—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing silicon
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L43/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium or a metal; Compositions of derivatives of such polymers
- C08L43/04—Homopolymers or copolymers of monomers containing silicon
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2033/00—Use of polymers of unsaturated acids or derivatives thereof as moulding material
- B29K2033/04—Polymers of esters
- B29K2033/12—Polymers of methacrylic acid esters, e.g. PMMA, i.e. polymethylmethacrylate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0002—Condition, form or state of moulded material or of the material to be shaped monomers or prepolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0058—Liquid or visquous
- B29K2105/0061—Gel or sol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
- C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages
Abstract
Description
ここで:
R1は、メタクリロイル、アクリロイル、スチリル、またはアリルを含むがこれらに限定されない重合性部分を含む基である。
R2は、構造(II)のシリコーン部分で終端されたC1-C15のアルケニル基を含む基であり、R2は、構造(II)のシリコーン部分で終端されたC1-C15アルケニル基を含む基であり、R4は-CH3または-[-Si(CH3)2-O-]n-Si(CH3)3のいずれかであり、n=0~50である。
R3は、ホスホリルコリン、ベタイン、スルホベタイン、または両性酢酸塩を含むがこれらに限定されない双性イオン基である。
さらに、化学構造から形成されるSiGMA-PCモノマー単位は、式(IV)および(V)に示される異性体構造のいずれか、またはそれらの混合物を含むことができる。
ここで、m+n≒5;平均M≒990g/molである。SiMA-PCモノマーは、米国特許第8,980,972号にさらに詳述されており、この特許は、それが開示するすべてについて参照により組み込まれ、そして以後、SiMA-PCモノマーと称される。
ここで:
R1は、メタクリロイル、アクリロイル、スチリル、またはアリルを含むがこれらに限定されない重合性部分を含む基である。
R2は、構造(II)のシリコーン部分で終端されたC1-C15のアルケニル基を含む基であり、R2は、構造(II)のシリコーン部分で終端されたC1-C15アルケニル基を含む基であり、R4は-CH3または-[-Si(CH3)2-O-]n-Si(CH3)3のいずれかであり、n=0~50である。
R3は、ホスホリルコリン、ベタイン、スルホベタイン、または両性酢酸塩を含むがこれらに限定されない双性イオン基である。
さらに、化学構造から形成されるSiGMA-PCモノマー単位は、式(IV)および(V)に示される異性体構造のいずれか、またはそれらの混合物を含むことができる。
ここで、m+n≒5;平均M≒990g/molである。
[総伸び:l(%)] = (z1L/L)×100 式(VII)
この実施例のセクションで詳しく説明されているように、総伸びは6つ以上の試験片の結果から得られた。
[応力緩和率:r(%)] = [(L1-L2)/L1]×100 式(VIII)
応力緩和率は、3つ以上の試験片の結果から得られた。
Claims (20)
- 組成物であって、
少なくとも1つの双性イオン基を含有する少なくとも1つのシリコーンモノマーを有し、前記組成物は0.1~9質量%のシリコーンである、組成物。 - 前記シリコーンモノマーが単一の双性イオン基を有する、請求項1に記載の組成物。
- 前記双性イオン基が、ホスホリルコリン、アルキルカルボベタイン、アルキルアミドカルボベタイン、アルキルスルホベタイン、アルキルヒドロキシスルホベタイン、アルキルアミドスルホベタイン、アルキルアミドヒドロキシスルホベタインおよびそれらのうちの1つを含む、請求項1又は2に記載の組成物。
- 前記組成物の緩和率が5.5%未満である、請求項1~3のいずれか1項に記載の組成物。
- 前記緩和率が4.0%未満である、請求項4に記載の組成物。
- 前記組成物の動摩擦が50mN未満である、請求項1~3のいずれか1項に記載の組成物。
- 前記動摩擦が40mN未満である、請求項6に記載の組成物。
- 前記シリコーンモノマーが、式(Ia)から(Ic)に示す異性体を含む、請求項1~7のいずれか一項に記載の組成物。
R1は、メタクリロイル、アクリロイル、スチリル、またはアリルを含むがこれらに限定されない重合性部分を含む基である。
R2は、構造(II)のシリコーン部分で終端されたC1-C15のアルケニル基を含む基であり、R2は、構造(II)のシリコーン部分で終端されたC1-C15アルケニル基を含む基であり、R4は-CH3または-[-Si(CH3)2-O-]n-Si(CH3)3のいずれかであり、n=0~50である。
R3は、ホスホリルコリン、ベタイン、スルホベタイン、または両性酢酸塩を含むがこれらに限定されない双性イオン基である。
- 前記組成物が、ホスホリルコリンを含有する0から10質量%の非シリコーンモノマーを含む、請求項8に記載の組成物。
- 眼科用レンズであって、
複数のモノマーを含むヒドロゲルポリマーであって、複数のモノマーは本体全体に分布する少なくとも1つの双性イオン基を含むシリコーンモノマーを含み、
装用者とは反対側を向くように構成された前面と、
装用者の眼に接触するように構成された後面と、
本体の前面と後面の間の点よりも前面により多く含まれる少なくとも1つの双性イオン基を含むシリコーンモノマーと、を含む本体を有する、眼科用レンズ。 - 前記ヒドロゲルポリマーの総シリコーン比が0.1~9質量%である、請求項10に記載の眼科用レンズ。
- 緩和率が5.5%未満である、請求項10または11に記載の眼科用レンズ。
- 動摩擦が50mN未満である、請求項10または11に記載の眼科用レンズ。
- 少なくとも1つの双性イオン基を含む前記シリコーンモノマーが、SiGMA-PCまたはSiMA-PCのうちの1つを含む、請求項10または11に記載の眼科用レンズ。
- 前記複数のモノマーが、グリセリルメタクリレート、(ヒドロキシエチル)メタクリレート、2-(4-ベンゾイル-3-ヒドロキシフェノキシ)エチルアクリレート、エチレングリコールジメタクリレート、ベンゾインメチルエーテルのうちの1つまたは複数、または前述のいずれかの組み合わせを含む、請求項14に記載の眼科用レンズ。
- 前記SiGMA-PCモノマーが前記ヒドロゲルポリマーの約0.5~約15質量パーセント(wt%)であり、グリセリルメタクリレートがヒドロゲルポリマーの約10wt%~約50wt%であり、前記2-ヒドロキシエチルメタクリレートが前記ヒドロゲルポリマーの約20wt%から約80wt%である、請求項15に記載の眼科用レンズ。
- 請求項14に記載の眼科用レンズであって、
前記本体は、前記後面よりも前記前面にSiGMA-PCまたはSiMA-PCの濃度が高くなっており、
前記眼科用レンズには、20を超える酸素透過率値(DK/厚さ)が含まれており、
前記眼科用レンズは、約0.1MPa~約0.5MPaのヤング率を示す。 - コンタクトレンズを作製する方法であって、
液体レンズ材料をモールドに注ぎ、
前記モールド内で前記液体レンズ材料を硬化させる、方法。
ここで、前記液体レンズ材料は、複数のモノマーを含み、前記複数のモノマーは、少なくともいくつかの3,5,8,13-テトラオキサ-4-ホスファ-12,14-ジシラペンタデカン-1-アミニウム、4-ヒドロキシ-N,N,N,12,14,14-ヘキサメチル-6-[[(2-メチル-1-オキソ-2-プロペン-1-イル)オキシ]メチル]-12-[(トリメチルシリル)オキシ]-,内塩,4-オキシド(「SiGMA-PC」)モノマーユニットを含む。 - 請求項18に記載の方法であって、前記モールドがスピンキャスト型を含み、
液体材料を硬化させることは、前記液体レンズ材料を少なくとも部分的に硬化させながら、回転させることを含む。 - 請求項18に記載の方法であって、前記モールドが鋳造型を含む。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862773402P | 2018-11-30 | 2018-11-30 | |
US62/773,402 | 2018-11-30 | ||
PCT/SG2019/050592 WO2020112030A1 (en) | 2018-11-30 | 2019-11-30 | Selectively wettable and oxygen-permeable lenses |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022514817A true JP2022514817A (ja) | 2022-02-16 |
Family
ID=70851874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021530958A Pending JP2022514817A (ja) | 2018-11-30 | 2019-11-30 | 選択的に濡れやすい、酸素透過性のレンズ |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220169765A1 (ja) |
EP (1) | EP3887408A4 (ja) |
JP (1) | JP2022514817A (ja) |
KR (1) | KR20210124200A (ja) |
CN (1) | CN113474381B (ja) |
CA (1) | CA3121326A1 (ja) |
SG (1) | SG11202105594TA (ja) |
TW (1) | TW202028338A (ja) |
WO (1) | WO2020112030A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2022224717A1 (ja) * | 2021-04-19 | 2022-10-27 | ||
TWI813431B (zh) * | 2022-08-29 | 2023-08-21 | 國立雲林科技大學 | 矽水凝膠組成物以及矽水凝膠鏡片 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4555372A (en) * | 1981-03-23 | 1985-11-26 | Bausch & Lomb Incorporated | Rotational molding of contact lenses |
US6346594B1 (en) * | 1998-09-21 | 2002-02-12 | Menicon Co., Ltd. | Ocular lens material and process for producing same |
WO2010147779A2 (en) * | 2009-06-15 | 2010-12-23 | Dsm Ip Assets B.V. | Phosphorylcholine-based amphiphilic silicones for medical applications |
US8980956B2 (en) * | 2011-09-01 | 2015-03-17 | Vertellus Specialities Inc. | Methods for producing biocompatible materials |
GB201119363D0 (en) * | 2011-11-10 | 2011-12-21 | Vertellus Specialities Inc | Polymerisable material |
CN103214636A (zh) * | 2013-04-17 | 2013-07-24 | 南京大学 | 含双键的两性离子化合物与偶联剂kh-570共聚物及其制法和用途 |
US20170088564A1 (en) * | 2015-09-25 | 2017-03-30 | Dsm Ip Assets B.V. | Silicone containing monomers with hydrophilic end groups |
-
2019
- 2019-11-29 TW TW108143790A patent/TW202028338A/zh unknown
- 2019-11-30 WO PCT/SG2019/050592 patent/WO2020112030A1/en unknown
- 2019-11-30 EP EP19889730.8A patent/EP3887408A4/en active Pending
- 2019-11-30 US US17/298,018 patent/US20220169765A1/en active Pending
- 2019-11-30 JP JP2021530958A patent/JP2022514817A/ja active Pending
- 2019-11-30 CN CN201980079165.3A patent/CN113474381B/zh active Active
- 2019-11-30 SG SG11202105594TA patent/SG11202105594TA/en unknown
- 2019-11-30 KR KR1020217020230A patent/KR20210124200A/ko unknown
- 2019-11-30 CA CA3121326A patent/CA3121326A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN113474381A (zh) | 2021-10-01 |
US20220169765A1 (en) | 2022-06-02 |
CA3121326A1 (en) | 2020-06-04 |
EP3887408A4 (en) | 2023-07-05 |
TW202028338A (zh) | 2020-08-01 |
CN113474381B (zh) | 2023-11-17 |
KR20210124200A (ko) | 2021-10-14 |
WO2020112030A4 (en) | 2020-07-23 |
SG11202105594TA (en) | 2021-06-29 |
EP3887408A1 (en) | 2021-10-06 |
WO2020112030A1 (en) | 2020-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11829008B2 (en) | Increased stiffness center optic in soft contact lenses for astigmatism correction | |
TWI786051B (zh) | 包含n-烷基甲基丙烯醯胺之聚矽氧水凝膠及其製得之隱形眼鏡與製造隱形眼鏡之方法 | |
AU2002323660B2 (en) | Biomedical devices containing internal wetting agents | |
KR101706813B1 (ko) | 극성 열가소성 안과용 렌즈 몰드, 몰드에서 성형된 안과용 렌즈 및 관련 방법 | |
US20140198294A1 (en) | Medical device, combination of coating solutions, and method for producing medical device | |
TW200935117A (en) | Method for making contact lenses | |
JP6486457B2 (ja) | 湿潤性表面を有するハイドロゲルコンタクトレンズ及びその製造方法 | |
KR20130041280A (ko) | 고비정질 비닐 알콜 중합체로부터 형성된 안과용 기구 몰드, 몰드에서 성형된 안과용 기구, 및 관련 방법 | |
TW201030408A (en) | Ophthalmic devices for delivery of hydrophobic comfort agents | |
TWI779424B (zh) | 眼科產品及其生產方法 | |
US20180312619A1 (en) | Acrylic copolymer, which is hydrophobic, cross-linked and based on cinnamic alcohol, for intraocular lenses | |
JP2022514817A (ja) | 選択的に濡れやすい、酸素透過性のレンズ | |
KR101647543B1 (ko) | 안과용 렌즈 몰드, 몰드에서 성형된 안과용 렌즈, 및 관련 방법 | |
JP7086924B2 (ja) | 乱視矯正用のソフトコンタクトレンズにおける剛性が増加した光心 | |
JP2023547481A (ja) | 高い屈折率及びアッベ数を有する組成物 | |
JP6956633B2 (ja) | 軟質コンタクトレンズ | |
CN101959664A (zh) | 可改善镜片移载的硅水凝胶眼镜片加工方法及系统 | |
US3822196A (en) | Fabrication of soft plastic contact lens blank and composition therefor | |
WO2012102332A1 (ja) | 老眼矯正体及び老眼矯正方法 | |
TWI704991B (zh) | 軟性矽酮醫療器材 | |
RU2779564C1 (ru) | Способы изготовления фотопоглощающих контактных линз и фотопоглощающие контактные линзы, полученные посредством их | |
WO2015060212A1 (ja) | コンタクトレンズおよびコンタクトレンズセット | |
JP2013011846A (ja) | 老眼矯正体及び老眼矯正方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A525 Effective date: 20210728 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221017 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231128 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240507 |